Yayın:
Olopatadine hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAKYIL, EVRİM
dc.contributor.authorEvrim Yenilmez
dc.contributor.orcid0000-0003-1547-0817
dc.contributor.orcid0000-0002-7979-0089
dc.date.accessioned2025-11-13T09:40:57Z
dc.date.issued2019-03-19
dc.identifier.doihttps://doi.org/10.1016/j.jddst.2019.03.016
dc.identifier.endpage512
dc.identifier.issn1773-2247
dc.identifier.openalexW2923330306
dc.identifier.startpage506
dc.identifier.urihttps://hdl.handle.net/11421/1867
dc.identifier.urihttps://doi.org/10.1016/j.jddst.2019.03.016
dc.identifier.volume51
dc.language.isoen
dc.relation.ispartofJournal of Drug Delivery Science and Technology
dc.rightsrestrictedAccess
dc.subjectZeta potential
dc.subjectNanoparticle
dc.subjectIn vivo
dc.subjectDrug delivery
dc.subjectMaterials science
dc.subjectChromatography
dc.subjectSpray drying
dc.subjectChemistry
dc.subjectBiomedical engineering
dc.subjectNanotechnology
dc.subjectMedicine
dc.subject.sdg3
dc.titleOlopatadine hydrochloride loaded Kollidon® SR nanoparticles for ocular delivery: Nanosuspension formulation and in vitro–in vivo evaluation
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5039882624

Dosyalar

Koleksiyonlar

Publications